Eva C Vlaar
Overview
Explore the profile of Eva C Vlaar including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Liang Q, Vlaar E, Pijnenburg J, Rijkers E, Demmers J, Vulto A, et al.
J Proteomics
. 2024 Jan;
291:105037.
PMID: 38288553
Pompe disease is a lysosomal storage disorder caused by deficiency of acid alpha-glucosidase (GAA), resulting in glycogen accumulation with profound pathology in skeletal muscle. We recently developed an optimized form...
2.
Catalano F, Vlaar E, Dammou Z, Katsavelis D, Huizer T, Zundo G, et al.
Hum Gene Ther
. 2023 Dec;
35(7-8):256-268.
PMID: 38085235
Deficiency of iduronate 2-sulfatase (IDS) causes Mucopolysaccharidosis type II (MPS II), a lysosomal storage disorder characterized by systemic accumulation of glycosaminoglycans (GAGs), leading to a devastating cognitive decline and life-threatening...
3.
Catalano F, Vlaar E, Katsavelis D, Dammou Z, Huizer T, van den Bosch J, et al.
Mol Ther Methods Clin Dev
. 2023 Nov;
31:101149.
PMID: 38033460
Mucopolysaccharidosis type II (OMIM 309900) is a lysosomal storage disorder caused by iduronate 2-sulfatase (IDS) deficiency and accumulation of glycosaminoglycans, leading to progressive neurodegeneration. As intravenously infused enzyme replacement therapy...
4.
Liang Q, Catalano F, Vlaar E, Pijnenburg J, Stok M, van Helsdingen Y, et al.
Mol Ther Methods Clin Dev
. 2022 Oct;
27:109-130.
PMID: 36284764
Pompe disease is caused by deficiency of acid α-glucosidase (GAA), resulting in glycogen accumulation in various tissues, including cardiac and skeletal muscles and the central nervous system (CNS). Enzyme replacement...
5.
Liang Q, Vlaar E, Catalano F, Pijnenburg J, Stok M, van Helsdingen Y, et al.
Mol Ther Methods Clin Dev
. 2022 Jun;
25:520-532.
PMID: 35662813
Enzyme replacement therapy (ERT) is the current standard treatment for Pompe disease, a lysosomal storage disorder caused by deficiency of the lysosomal enzyme acid alpha-glucosidase (GAA). ERT has shown to...